The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Results of COMFORT-I, a randomized double-blind phase III trial of JAK 1/2 inhibitor INCB18424 (424) versus placebo (PB) for patients with myelofibrosis (MF).
S. Verstovsek
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; Geron; Incyte; Lilly; Roche; S*Bio
R. A. Mesa
Research Funding - Celgene; Incyte; S*Bio
J. R. Gotlib
Research Funding - Incyte
R. S. Levy
Employment or Leadership Position - Incyte
Stock Ownership - Incyte
V. Gupta
No relevant relationships to disclose
J. F. DiPersio
Research Funding - Genzyme
J. Catalano
No relevant relationships to disclose
M. Deininger
Consultant or Advisory Role - ARIAD; Bristol-Myers Squibb; Incyte; Novartis
Honoraria - ARIAD; Bristol-Myers Squibb; Incyte; Novartis
Research Funding - Bristol-Myers Squibb; Celgene; Genzyme
C. B. Miller
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Incyte
R. T. Silver
Stock Ownership - Incyte
Research Funding - Incyte
M. Talpaz
Research Funding - Incyte
E. F. Winton
No relevant relationships to disclose
J. H. Harvey
No relevant relationships to disclose
K. Vaddi
Employment or Leadership Position - Incyte
Stock Ownership - Incyte
S. K. Erickson-Viitanen
Employment or Leadership Position - Incyte
Stock Ownership - Incyte
I. Koumenis
Employment or Leadership Position - Incyte
W. Sun
Employment or Leadership Position - Incyte
Stock Ownership - Incyte
V. Sandor
Employment or Leadership Position - Incyte
Stock Ownership - Incyte
H. Kantarjian
Consultant or Advisory Role - Novartis
Research Funding - Bristol-Myers Squibb; Novartis; Pfizer